Traphaco looking steady at threshold into 2021

Traphaco was honoured for the fifth consecutive year at the National Brand Awards on November 25

Debuting since 2008, the Vietnam national brand programme (Vietnam Value) aims to boost the competitiveness of made-in-Vietnam products in the domestic and international market during integration process.

Vietnam Value calls on businesses to pursue the values that the country is yearning for – quality, innovation, pioneering – that are also Traphaco’s top targets to bolster its competitiveness, attract talents, and enhance its distinction and business value.

Pioneering drug development using top-quality herbs, the company has been deploying a sustainable pharmaceutical material development model. Traphaco is also the first local company having six GACP-WHO standard herbal areas that have grown six kinds of herbs (Dinh lang, Bach qua, Rau dang dat, Actiso, Bim bim, and Che day).

In light of its sustainable development strategy for 2017-2020, Traphaco aims to stay at the forefront of the Pharma 4.0 trend by applying leading technology into its operations.

In 2017, Traphaco built the smart drug factory that features fully robotised and automated production lines.

Traphaco’s new drug segment and smart factory are operating without a hitch, showing very buoyant growth prospects

In the forthcoming years, the company will continue to smarten up its technology portfolio through technology transfer (exclusive import included) from global pharmaceutical makers. Traphaco’s new drug segment and smart factory are operating without a hitch, showing very buoyant growth prospects.

Aside from the National Brand award, on this upcoming December 10, Traphaco is expected to receive the Vietnam Sustainable Enterprise Award 2020, attesting to the company’s sustainable development strategy which is based on three pillars: economic development closely attached to corporate social responsibility and environmental protection.

Consistent with its sustainable development strategy and promoting its inherent core values, Traphaco JSC was quickly adapting to new circumstances to steer through pandemic turbulences, while simultaneously making it onto the list of prestigious brands favoured by consumers and customers.

The company’s third quarter 2020 business results showcased a 22.4 per cent jump in revenue and 23.8 per cent hike in gross profit on-year. In the first nine months, Traphaco witnessed 11.4 and 32.5 per cent jumps in revenue and profit compared to the corresponding period in 2019. This was the single best performance among listed pharmaceutical firms in the Vietnamese stock exchanges.

In the last quarter of 2020, Traphaco’s executives are confident the company will continue its growth momentum and is on a solid path to reach its full-year targets despite COVID-19 impacts.

Its growth prospects for 2021 are upbeat. Along with this, besides capitalising on its existing advantages, Traphaco will also utilise its strong distribution network, push up research and development activities to scale up technology transfer, and lay down the premises for new, efficient product lineups.